Journal Highlight: Prostate cancer outcome and tissue levels of metal ions

Skip to Navigation

Ezine

  • Published: Sep 5, 2011
  • Channels: Atomic
thumbnail image: Journal Highlight: Prostate cancer outcome and tissue levels of metal ions

Prostate cancer outcome and tissue levels of metal ions

The Prostate 2011, 71, 1231-1238
Andrey G. Sarafanov, Todor I. Todorov, Jose A. Centeno, Virgilia Macias, Weihua Gao, Wei-Min Liang, Craig Beam, Marion A. Gray, Andre A. Kajdacsy-Balla

Abstract: There are several studies examining prostate cancer and exposure to cadmium, iron, selenium, and zinc. Less data are available on the possible influence of these metal ions on prostate cancer outcome. This study measured levels of these ions in prostatectomy samples in order to examine possible associations between metal concentrations and disease outcome. We obtained formalin fixed paraffin embedded tissue blocks of prostatectomy samples of 40 patients with PSA recurrence, matched 1:1 (for year of surgery, race, age, Gleason grading, and pathology TNM classification) with tissue blocks from 40 patients without recurrence (n = 80). Case-control pairs were compared for the levels of metals in areas adjacent to tumors. Inductively coupled plasma-mass spectrometry (ICP-MS) was used for quantification of Cd, Fe, Zn, and Se. Patients with biochemical (PSA) recurrence of disease had 12% lower median iron (95 µg/g vs. 111 µg/g; P = 0.04) and 21% lower zinc (279 µg/g vs. 346 µg/g; P = 0.04) concentrations in the normal-appearing tissue immediately adjacent to cancer areas. Differences in cadmium (0.489 µg/g vs. 0.439 µg/g; 4% higher) and selenium (1.68 µg/g vs. 1.58 µg/g; 5% higher) levels were not statistically significant in recurrence cases, when compared to non-recurrences (P = 0.40 and 0.21, respectively). There is an association between low zinc and low iron prostate tissue levels and biochemical recurrence in prostate cancer. Whether these novel findings are a cause or effect of more aggressive tumors, or whether low zinc and iron prostatic levels raise implications for therapy, remains to be investigated.

  • This paper is free to view to spectroscopyNOW registered users until the end of October 2011. After this time it will be available via Wiley's Pay-Per-View service for US$29.95.
  • Click here to access the abstract of this paper. From here you can progress to read the full paper.
  • Click here for more details about The Prostate

  


 

 

     
     

 

 
 ICP-MS was used for quantification of Cd, Fe, Zn, and Se ions in prostatectomy samples, revealing an association between low Zn and low Fe prostate tissue levels and biochemical recurrence in prostate cancer

Social Links

Share This Links

Bookmark and Share

Microsites

Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2017 John Wiley & Sons, Inc. All Rights Reserved